Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosis

Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosis

There is currently no diagnostic or prognostic biomarker available in clinical practice for Amyotrophic Lateral Sclerosis (ALS). The objective of this study was to monitor a combination of various inflammatory markers, lipids, and apolipoproteins alterations in ALS patients at the time of diagnosis,...

Full description

Bibliographic Details
Main Authors: Hugo Alarcan, Mélanie Berthet, Laura Suire, Corentin Colas, Loïc Gonzalez, Christophe Paget, Isabelle Benz-de Bretagne, Eric Piver, Patrick Vourc'h, Christian Andres, Philippe Corcia, Hélène Blasco
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:SLAS Technology
Subjects:
Amyotrophic lateral sclerosis
Lipids
Apolipoproteins
Inflammatory mediators
PLS-DA
Online Access:http://www.sciencedirect.com/science/article/pii/S2472630322051652

Internet

http://www.sciencedirect.com/science/article/pii/S2472630322051652

Similar Items